Abstract
Background
Annual surveillance mammography is recommended for follow-up of women with a history of breast cancer. We examined surveillance mammography among breast cancer survivors who were enrolled in integrated healthcare systems.
Methods
Women in this study were 65 or older when diagnosed with early stage invasive breast cancer (N = 1,762). We assessed mammography use during 4 years of follow-up, using generalized estimating equations to account for repeated measurements.
Results
Eighty-two percent had mammograms during the first year after treatment; the percentage declined to 68.5% in the fourth year of follow-up. Controlling for age and comorbidity, women who were at higher risk of recurrence by being diagnosed at stage II or receiving breast-conserving surgery (BCS) without radiation therapy were less likely to have yearly mammograms (compared to stage I, odds ratio [OR] for stage IIA 0.72, confidence interval [CI] 0.59, 0.87, OR for stage IIB 0.75, CI 0.57, 1.0; compared to BCS with radiation, OR 0.58, CI 0.43, 0.77). Women with visits to a breast cancer surgeon or oncologist were more likely to receive mammograms (OR for breast cancer surgeon 6.0, CI 4.9, 7.4, OR for oncologist 7.4, CI 6.1, 9.0).
Conclusions
Breast cancer survivors who are at greater risk of recurrence are less likely to receive surveillance mammograms. Women without a visit to an oncologist or breast cancer surgeon during a year have particularly low rates of mammography. Improvements to surveillance care for breast cancer survivors may require active participation by primary care physicians and improvements in cancer survivorship programs by healthcare systems.
Similar content being viewed by others
References
Grunfeld E, Noorani H, McGahan L, et al. Surveillance mammography after treatment of primary breast cancer: a systematic review. Breast. 2002;11:228–35.
Woodward WA, Strom EA, Tucker SL, et al. Changes in the 2003 American Joint Committee on Cancer Staging for Breast Cancer dramatically affect stage-specific survival. J Clin Oncol. 2003;21:3244–8.
Lash TL, Silliman RA, Guadagnoli E, Mor V. The effect of less than definitive care on breast carcinoma recurrence and mortality. Cancer. 2000;89:1739–47.
Smith BD, Gross CP, Smith GL, et al. Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst. 2006;98:681–90.
Early Breast Cancer Trialists’ Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687–717.
Khatcheressian JL, Wolff AC, Smith TH, et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006;24:5091–7.
Schapira MM, McAuliffe TL, Nattinger AB. Underutilization of mammography in older breast cancer survivors. Med Care. 2000;38:281–9.
Lash TL, Silliman RA. Medical surveillance after breast cancer diagnosis. Med Care. 2001;39:945–55.
Geller BM, Kerlikowske K, Carney PA, et al. Mammography surveillance following breast cancer. Breast Cancer Res Treat. 2003;81:107–15.
Keating NL, Landrum MB, Guadagnoli E, Winer RP, Ayanian JZ. Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol. 2006;24:85–94.
Doubeni CA, Field TS, Yood MU, et al. Patterns and predictors of mammography utilization among breast cancer survivors. Cancer. 2006;106:2482–8.
Enger SM, Thwin S, Buist DS, et al. Breast cancer treatment of older women in integrated health care settings. J Clin Oncol. 2006;24:4377–83.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373–83.
GIVIO Investigators. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients: a multicenter randomized controlled trial. JAMA. 1994;271:1587–92.
Del Truco M, Palli D, Cariddi A, et al. Intensive diagnostic follow-up after treatment of primary breast cancer: a randomized trial. JAMA. 1994;271:1593–7.
Nystrom L, Andersson I, Bjurstam N, et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. The Lancet. 2002;359:909–19.
Samant RS, Olivotto IA, Jackson JSH, Mates D. Diagnosis of metachronous contralateral breast cancer. Breast J. 2001;7:405–10.
Voogd AC, van Tienhoven G, Peterse HL, et al. Local recurrence after breast conservatioin therapy for early stage breast carcinoma. Cancer. 1999;85:437–46.
Lash TL, Clough-Gorr K, Silliman RA. Reduced rates of cancer-related worries and mortality associated with guideline surveillance after breast cancer therapy. Breast Cancer Res Treat. 2005;89:61–7.
Geiger AM, Thwin SS, Lash TL, et al. Recurrences and second primary breast cancers in older women with early stage disease initially. Cancer. 2007;109:966–74.
Lash TL, Fox MP, Buist DSM, et al. Mammography surveillance and mortality in older breast cancer survivors. J Clin Oncol. 2007;25:3001–6.
Hewitt M, Greenfield S, Stovall E, eds. In: From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC: The National Academies; 2006.
Taplin SH, Urban N, Taylor VM, Savarino J. Conflicting national recommendations and the use of screening mammography: does the physician’s recommendation matter? J Am Board Fam Pract. 1997;10:88–95.
Grunfeld E, Levine MN, Julian JA, et al. Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol. 2006;24:848–55.
Taplin SH, Ichikawa L, Buist DSM, Seger D, White E. Evaluating organized breast cancer screening implementation: the prevention of late-stage disease. Cancer Epi, Biomarkers & Prev. 2004;13:225–34.
Acknowledgments
This study was supported by a grant from the National Cancer Institute (R01 CA093772 R. Silliman, PI). A number of people assisted in the conduct of this study, including project managers, programmers, and medical record abstractors: Group Health—Linda Shultz, Kristin Delaney, Margaret Farrell-Ross, Mary Sunderland, Millie Magner, and Beth Kirlin; Meyers Primary Care Institute and Fallon Clinic—Jackie Fuller, Doris Hoyer, and Janet Guilbert; Henry Ford Health System—Sharon Hensley Alford, Karen Wells, Patricia Baker, and Rita Montague; HealthPartners—Maribet McCarty and Alex Kravchik; Kaiser Permanente Southern California—Julie Stern, Janis Yao, and Michelle McGuirel; and Lovelace Health Plan—Judity Hurley, Hans Petersen, and Melissa Roberts. Three of the authors (FW, VPQ, MUY) have received funding from pharmaceutical companies.
Conflict of interest
None disclosed.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Field, T.S., Doubeni, C., Fox, M.P. et al. Under Utilization of Surveillance Mammography among Older Breast Cancer Survivors. J GEN INTERN MED 23, 158–163 (2008). https://doi.org/10.1007/s11606-007-0471-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11606-007-0471-2